Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 28, 2015 11:21 PM ET

Healthcare Providers and Services

Company Overview of KEW Group LLC

Company Overview

KEW Group LLC provides DNA based genomic testing and interpretation services with evidence-based diagnostic and treatment pathways to oncology practices. The company offers Therapeutic Pathways, a platform for personalized medicine, which provides information about current and emerging therapies, and is deployed in Web-based format for oncology practitioners and other healthcare workers; and KEW CancerPlexSM symbol, a gene testing panel to evaluate genetic changes in a patient's tumor to help oncologists manage treatment options. It also provides molecular genetic testing services, which determine whether a particular individual is at risk to develop certain types of cancers or examination o...

790 Memorial Drive

Suite 101

Cambridge, MA 02139

United States

Founded in 2009

Phone:

617-945-7922

Fax:

857-259-6965

Key Executives for KEW Group LLC

Chief Executive Officer, President and Director
Co-Founder and Chairman of the Board
Age: 71
Co-Founder and Director
Co-Founder, Director and Clinical Quality Board Chairman
Co-Founder and Board Observer
Compensation as of Fiscal Year 2014.

KEW Group LLC Key Developments

KEW Group Appoints Tom J. Miller as an Independent Director

KEW Group recently reported that Thomas (Tom) J. Miller, Jr. has joined its Board of Directors as an independent director. According to a release, a seasoned executive in the diagnostic space, Miller previously served as Chief Executive Officer (CEO) of Siemens Healthcare's Customer Solutions Division, responsible for an organization of 26,000 employees in more than 130 countries. He also held other leadership roles during his tenure at Siemens, including serving as a member of the Group Board of Siemens Medical Solutions, as well as overseeing the company's global MRI business. In addition to his leadership roles with Siemens, Miller has served as CEO for several other organizations, including Global Medical Operations of Carl Zeiss Inc.; Analogic Corp.; and LightLab Imaging, a start-up he helped to establish and sell, and for whom he also served as Chairman. In April 2013, he founded GreyBird Ventures, a consultancy and investment firm, where he currently serves as director, advisor, and/or investor in six healthcare start-up companies.

KEW Group Inc. Appoints Thomas (Tom) J. Miller, Jr. to its Board of Directors as an Independent Director

KEW Group Inc. announced that Thomas (Tom) J. Miller, Jr. has joined its Board of Directors as an independent director. A seasoned executive in the diagnostic space, Mr. Miller previously served as Chief Executive Officer (CEO) of Siemens Healthcare’s Customer Solutions Division, responsible for an organization of 26,000 employees in more than 130 countries. He also held other leadership roles during his tenure at Siemens, including serving as a member of the Group Board of Siemens Medical Solutions, as well as overseeing the company’s global MRI business.

Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists

Cardinal Health Specialty Solutions and KEW Group Inc. announced an agreement for the two companies to make KEW's diagnostic services available to Specialty Solutions' community oncology customers. Cardinal Health Specialty Solutions customers will now have access to KEW's CancerPlex. CancerPlex: Simultaneously provides complete sequence coverage of more than 410 cancer genes; Simplifies and streamlines the test-ordering process by eliminating serial "hotspot" tests; Delivers a comprehensive report, including actionable data; Informs physicians of optimal treatment options using approved therapies and available clinical trials; and Supports clinical trial enrollment by providing oncologists with required molecular data.

Similar Private Companies By Industry

Company Name Region
ABC Health Plan United States
Community Concepts, Inc. United States
McAuley Center, Inc. United States
WESTMED Medical Group, P.C. United States
Absentee Shawnee Counseling Services United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 5, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KEW Group LLC, please visit www.kewgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.